US Stock MarketDetailed Quotes

ONCE Spark Therapeutics

Watchlist
  • 0.000
  • 0.0000.00%
Trading Aug 14 09:30 ET
0Market Cap0.00P/E (TTM)

Spark Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2019
(Q2)Jun 30, 2019
(Q1)Mar 31, 2019
(FY)Dec 31, 2018
(Q4)Dec 31, 2018
(Q3)Sep 30, 2018
(Q2)Jun 30, 2018
(Q1)Mar 31, 2018
(FY)Dec 31, 2017
(Q4)Dec 31, 2017
Total revenue
109.65%22.45M
-46.38%13.5M
32.50%20.77M
436.42%64.73M
77.58%13.16M
463.53%10.71M
1,598.25%25.19M
1,130.46%15.68M
-40.22%12.07M
-54.55%7.41M
Operating revenue
109.65%22.45M
-46.38%13.5M
32.50%20.77M
436.42%64.73M
77.58%13.16M
463.53%10.71M
1,598.25%25.19M
1,130.46%15.68M
-40.22%12.07M
-54.55%7.41M
Cost of revenue
1,485.85%5.04M
-71.25%1.3M
253.03%3.5M
7.92M
2.1M
318K
4.51M
990K
0
0
Gross profit
67.52%17.4M
-40.96%12.21M
17.64%17.28M
370.83%56.81M
49.29%11.06M
446.79%10.39M
20.67M
1,052.75%14.69M
-40.22%12.07M
7.41M
Operating expense
38.51%86.06M
42.30%78.65M
16.55%74.12M
-1.74%250.45M
-1.10%69.44M
-8.26%62.13M
-11.97%55.27M
17.45%63.6M
75.08%254.89M
30.70%70.22M
Selling and administrative expenses
41.30%41.41M
22.38%36.41M
14.34%38.29M
12.39%124.9M
-10.98%32.35M
10.00%29.31M
11.30%29.75M
56.40%33.49M
131.17%111.12M
120.66%36.34M
-General and administrative expense
41.30%41.41M
22.38%36.41M
14.34%38.29M
12.39%124.9M
-10.98%32.35M
10.00%29.31M
11.30%29.75M
56.40%33.49M
131.17%111.12M
120.66%36.34M
Research and development costs
36.02%44.66M
65.51%42.24M
19.00%35.83M
-12.67%125.55M
9.49%37.09M
-20.11%32.83M
-29.22%25.52M
-8.02%30.11M
47.43%143.76M
-9.06%33.88M
Operating profit
-32.69%-68.66M
-92.04%-66.45M
-16.22%-56.85M
20.25%-193.64M
7.05%-58.38M
21.40%-51.75M
43.56%-34.6M
7.49%-48.91M
-93.64%-242.82M
-67.85%-62.81M
Net non-operating interest income expense
-22.81%2.1M
5.91%2.67M
23.66%2.7M
145.37%9.99M
39.74%2.57M
144.06%2.71M
373.87%2.52M
273.50%2.19M
133.28%4.07M
215.86%1.84M
Total other finance cost
22.81%-2.1M
-5.91%-2.67M
-23.66%-2.7M
-145.37%-9.99M
-39.74%-2.57M
-144.06%-2.71M
-373.87%-2.52M
-273.50%-2.19M
-133.28%-4.07M
-215.86%-1.84M
Other net income (expense)
-100.78%-13K
-100.38%-422K
-157.97%-211K
768.46%104.92M
-9.37M
1.67M
815.18%112.26M
364K
-15.7M
0
Gain on sale of security
-100.78%-13K
-118.71%-422K
-157.97%-211K
---5.08M
---9.37M
--1.67M
--2.26M
--364K
----
----
Special income (charges)
----
----
----
--0
----
----
----
----
---15.7M
--0
-Less:Impairment of capital assets
----
----
----
--0
----
----
----
----
--15.7M
--0
Other non- operating income (expenses)
----
----
----
--110M
--0
----
--110M
----
----
----
Income before tax
-40.58%-66.58M
-180.07%-64.2M
-17.24%-54.36M
69.06%-78.72M
-6.91%-65.18M
26.82%-47.36M
204.85%80.18M
11.33%-46.36M
-105.77%-254.45M
-65.50%-60.97M
Income tax
1,400.00%26K
175.00%33K
-70.00%3K
110.28%99K
-90.74%79K
-100.68%-2K
100.57%12K
10K
-963K
853K
Net income
-40.64%-66.6M
-180.12%-64.23M
-17.22%-54.36M
68.90%-78.82M
-5.56%-65.26M
27.16%-47.36M
207.81%80.17M
11.31%-46.37M
-104.99%-253.48M
-67.82%-61.82M
Net income continuous Operations
-40.64%-66.6M
-180.12%-64.23M
-17.22%-54.36M
68.90%-78.82M
-5.56%-65.26M
27.16%-47.36M
207.81%80.17M
11.31%-46.37M
-104.99%-253.48M
-67.82%-61.82M
Minority interest income
Net income attributable to the parent company
-40.64%-66.6M
-180.12%-64.23M
-17.22%-54.36M
68.90%-78.82M
-5.56%-65.26M
27.16%-47.36M
207.81%80.17M
11.31%-46.37M
-104.99%-253.48M
-67.82%-61.82M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-40.64%-66.6M
-180.12%-64.23M
-17.22%-54.36M
68.90%-78.82M
-5.56%-65.26M
27.16%-47.36M
207.81%80.17M
11.31%-46.37M
-104.99%-253.48M
-67.82%-61.82M
Basic earnings per share
-36.51%-1.72
-177.21%-1.66
-14.40%-1.43
72.35%-2.11
-0.57%-1.75
33.68%-1.26
189.58%2.15
26.47%-1.25
-77.86%-7.63
-43.80%-1.74
Diluted earnings per share
-36.51%-1.72
-180.19%-1.66
-14.40%-1.43
72.35%-2.11
-0.57%-1.75
33.68%-1.26
186.25%2.07
26.47%-1.25
-77.86%-7.63
-43.80%-1.74
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2019(Q2)Jun 30, 2019(Q1)Mar 31, 2019(FY)Dec 31, 2018(Q4)Dec 31, 2018(Q3)Sep 30, 2018(Q2)Jun 30, 2018(Q1)Mar 31, 2018(FY)Dec 31, 2017(Q4)Dec 31, 2017
Total revenue 109.65%22.45M-46.38%13.5M32.50%20.77M436.42%64.73M77.58%13.16M463.53%10.71M1,598.25%25.19M1,130.46%15.68M-40.22%12.07M-54.55%7.41M
Operating revenue 109.65%22.45M-46.38%13.5M32.50%20.77M436.42%64.73M77.58%13.16M463.53%10.71M1,598.25%25.19M1,130.46%15.68M-40.22%12.07M-54.55%7.41M
Cost of revenue 1,485.85%5.04M-71.25%1.3M253.03%3.5M7.92M2.1M318K4.51M990K00
Gross profit 67.52%17.4M-40.96%12.21M17.64%17.28M370.83%56.81M49.29%11.06M446.79%10.39M20.67M1,052.75%14.69M-40.22%12.07M7.41M
Operating expense 38.51%86.06M42.30%78.65M16.55%74.12M-1.74%250.45M-1.10%69.44M-8.26%62.13M-11.97%55.27M17.45%63.6M75.08%254.89M30.70%70.22M
Selling and administrative expenses 41.30%41.41M22.38%36.41M14.34%38.29M12.39%124.9M-10.98%32.35M10.00%29.31M11.30%29.75M56.40%33.49M131.17%111.12M120.66%36.34M
-General and administrative expense 41.30%41.41M22.38%36.41M14.34%38.29M12.39%124.9M-10.98%32.35M10.00%29.31M11.30%29.75M56.40%33.49M131.17%111.12M120.66%36.34M
Research and development costs 36.02%44.66M65.51%42.24M19.00%35.83M-12.67%125.55M9.49%37.09M-20.11%32.83M-29.22%25.52M-8.02%30.11M47.43%143.76M-9.06%33.88M
Operating profit -32.69%-68.66M-92.04%-66.45M-16.22%-56.85M20.25%-193.64M7.05%-58.38M21.40%-51.75M43.56%-34.6M7.49%-48.91M-93.64%-242.82M-67.85%-62.81M
Net non-operating interest income expense -22.81%2.1M5.91%2.67M23.66%2.7M145.37%9.99M39.74%2.57M144.06%2.71M373.87%2.52M273.50%2.19M133.28%4.07M215.86%1.84M
Total other finance cost 22.81%-2.1M-5.91%-2.67M-23.66%-2.7M-145.37%-9.99M-39.74%-2.57M-144.06%-2.71M-373.87%-2.52M-273.50%-2.19M-133.28%-4.07M-215.86%-1.84M
Other net income (expense) -100.78%-13K-100.38%-422K-157.97%-211K768.46%104.92M-9.37M1.67M815.18%112.26M364K-15.7M0
Gain on sale of security -100.78%-13K-118.71%-422K-157.97%-211K---5.08M---9.37M--1.67M--2.26M--364K--------
Special income (charges) --------------0-------------------15.7M--0
-Less:Impairment of capital assets --------------0------------------15.7M--0
Other non- operating income (expenses) --------------110M--0------110M------------
Income before tax -40.58%-66.58M-180.07%-64.2M-17.24%-54.36M69.06%-78.72M-6.91%-65.18M26.82%-47.36M204.85%80.18M11.33%-46.36M-105.77%-254.45M-65.50%-60.97M
Income tax 1,400.00%26K175.00%33K-70.00%3K110.28%99K-90.74%79K-100.68%-2K100.57%12K10K-963K853K
Net income -40.64%-66.6M-180.12%-64.23M-17.22%-54.36M68.90%-78.82M-5.56%-65.26M27.16%-47.36M207.81%80.17M11.31%-46.37M-104.99%-253.48M-67.82%-61.82M
Net income continuous Operations -40.64%-66.6M-180.12%-64.23M-17.22%-54.36M68.90%-78.82M-5.56%-65.26M27.16%-47.36M207.81%80.17M11.31%-46.37M-104.99%-253.48M-67.82%-61.82M
Minority interest income
Net income attributable to the parent company -40.64%-66.6M-180.12%-64.23M-17.22%-54.36M68.90%-78.82M-5.56%-65.26M27.16%-47.36M207.81%80.17M11.31%-46.37M-104.99%-253.48M-67.82%-61.82M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -40.64%-66.6M-180.12%-64.23M-17.22%-54.36M68.90%-78.82M-5.56%-65.26M27.16%-47.36M207.81%80.17M11.31%-46.37M-104.99%-253.48M-67.82%-61.82M
Basic earnings per share -36.51%-1.72-177.21%-1.66-14.40%-1.4372.35%-2.11-0.57%-1.7533.68%-1.26189.58%2.1526.47%-1.25-77.86%-7.63-43.80%-1.74
Diluted earnings per share -36.51%-1.72-180.19%-1.66-14.40%-1.4372.35%-2.11-0.57%-1.7533.68%-1.26186.25%2.0726.47%-1.25-77.86%-7.63-43.80%-1.74
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg